Tuesday, May 13, 2008

Drop patent regulations, generic drug makers urge

From the Globe and Mail:
Canada's generic drug companies are urging Parliament to abandon proposed regulations that would delay their ability to reproduce some of the most popular name-brand drugs that are currently on the market, including Viagra and Lipitor.

Jim Keon, the president of the Canadian Generic Pharmaceutical Association, said his organization is considering taking the government to court to reverse the regulations that he says will cost Canadians hundreds of millions of dollars every year.

The changes to Canada's drug patent regime appeared in the Canada Gazette, the formal record of government notices, two weeks ago.

Under the new rules, patents that have been removed from drugs that were on the market prior to June 17, 2006, could be reinstated. ...more

No comments: